Narrowband Ultraviolet B Phototherapy of Early Stage Mycosis Fungoides in Korean Patients

Narrowband Ultraviolet B Phototherapy of Early Stage Mycosis Fungoides in Korean Patients

BACKGROUND Narrowband UVB (NBUVB) is currently used to treat early mycosis fungoides (MF). There are a number of reports on the efficacy and safety of NBUVB in Caucasians, but little data is available for Asians. OBJECTIVE This study was designed to evaluate the effectiveness and safety of NBUVB for early stage MF in Korean patients. METHODS We enrolled 14 patients (12 men, 2 women; age ran...

Ultraviolet-B phototherapy is successful in Japanese patients with early-stage mycosis fungoides.

UVB phototherapy is widely used for the treatment of psoriasis and atopic dermatitis, however, only limited reports evaluate its usefulness in the treatment of mycosis fungoides. We introduced UVB phototherapy to five patients with early-stage mycosis fungoides. All of them were classified as stage IB (erythematous stage), and none had obtained a satisfactory response to other therapies. After ...

Ultraviolet A1 Phototherapy of Mycosis Fungoides

Received May 13, 2011, Revised July 30, 2011, Accepted for publication October 16, 2011 Corresponding author: Kee Suck Suh, Department of Dermatology, Kosin University College of Medicine, 262 Gamcheon-ro, Seo-gu, Busan 602-702, Korea. Tel: 82-51-990-6145, Fax: 82-51-990-3041, E-mail: [email protected] This is an Open Access article distributed under the terms of the Creative Commons Attrib...

PUVA phototherapy-induced secondary amyloidosis in patients with mycosis fungoides: a rare adverse effect of phototherapy.

AIM Amyloidosis is a common disorder in adults. Secondary amyloidosis in patients with mycosis fungoides (MF) after photochemotherapy with 8-methoxypsoralen followed by ultraviolet A (PUVA) treatment has not been reported. Our aim is to describe the clinical and histological features of PUVA phototherapy-induced secondary amyloidosis. MATERIALS AND METHODS Sixty-one patients with MF treated w...

Photocarcinogenic risk of narrowband ultraviolet B (TL-01) phototherapy: early follow-up data.